The natural history of hepatitis C: Clinical experiences

Journal of Hepatology, Supplement

Volumn 24, Issue 2, 1996, Pages 52-54

  Muller R ^a  

^a Krankenhaus   (Germany)

Author keywords

Chronicity; Hepatis C

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; RHESUS D ANTIBODY; VIRUS RNA;

COHORT ANALYSIS; CONFERENCE PAPER; DISEASE COURSE; ENZYME ACTIVITY; EPIDEMIC; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; RNA ANALYSIS;

CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; RNA, VIRAL;

EID: 0029791849     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
2. Wiese M, Haupt R, Kirsch WD. Zum gegenwärtigen Erkenntnisstand bei Non-A-Non-B-Hepatitis (NANBH) - Eigene Ergebnisse zu Klinik und Epidemiologie. Z Klin Med 1988; 43 (9): 759-64.
3. Dittmann S, Roggendorf M, Dürkop J, Wiese M, Lorbeer B, Deinhardt F. Preliminary results of a long-term follow-up of antibody response to hepatitis C virus infections after administration of contaminated immunoglobulin. In: Hollinger FB, Lemon StM, Margolis HS, eds. Viral Hepatitis and Liver Disease. Baltimore: Williams and Wilkins, 1991: 422-3.
4. Duetscher Bundestag, 13. Wahlperiode; Bundesdrucksache 13/2732 vom 24.10.1995. Bonn: Bundesanzeiger Verlagsgesellschaft mbH, 1995.
5. Esteban JI, Lopez-Talavera JC, Genesca J, Madoz P, Viladomiu L, Muniz E, Martin-Vega C, Rosell M, Allende H, Vidai X. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991; 115:443-9.
6. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Pin Ya Hu, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899-1905.
7. Albert! A, Chemello L, Cavalletto D, Tagger A, Dal-Canton A, Bizzaro N, Tagariello G, Ruol A. Antibody to hepatitis C virus and liver disease in volunteer blood donors. Ann Intern Med 1991; 114: 1010-2.
8. Kodama T, Tamaki T, Katabami Sh, Katamuma A, Yamashita K, Azuma N, Kamijo K, Kinoshita H, Yachi A. Histological findings in asymptomatic hepatitis C virus carriers. J Gastroenterol Hepatol 1993; 8: 403-5.
9. McMahon RFT, Yates AJ, McLindon J, Babbs C, Love EM, Warnes TW. The histopathological features of asymptomatic hepatitis C virus-antibody positive blood donors. Histopathology 1994; 24: 517-24.
10. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, Kamada T. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 1994; 19: 871-5.
11. Cheung RC, Chan RT, Lok ASF. Longitudinal study of hepatitis C viremia in chronic hepatitis C. J Med Virol 1993; 41: 338-442.
12. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, Purcell RH. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991; 325: 98-104.
13. Garson JA, Tuke P\V, Makris M, Briggs M, Machin SJ, Preston FE, Tedder RS. Demonstration of viremia patterns in haemophiliacs treated with hepatitis C virus contaminated factor VIII concentrates. Lancet 1990; 336: 1022-5.
14. Meng ZD, Sun DG, Liu CY, Copland J, Gowans EJ. A dynamic study of viraemia in chronic hepatitis C infection. J Gastroenterol Hepatol 1994; 9: 242-4.
15. Brechot C. Hepatitis C virus genetic variability: clinical implications. In: Groupe Français d'Etudes Moléculaires de Hepatitis. GEMHEP eds. Hepatitis C Virus: New Diagnostics Tools. Paris: John Libbey Eurotext, 1994: 1-15.
16. Dusheiko G, Schmilovitz-Qeiss H, Brown D, McOmish F, Pong-Lee Y, Sherlock S, Mclntyre N, Simmonds P. Hepatitis C virus génotypes: An investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19: 13-8.
17. Miyamara T. Analysis of the hepatitis C virus genome and hepatocellular carcinoma. In: Brechot C, ed. Primary Liver Cancer, Etiological and Progression Factors. London: CRC Press, 1994: 125-36.
18. Colombo M, Romeo R. Hepatitis C virus infection and hepatocellular carcinoma. In: Brechot C, ed. Primary Liver Cancer: Etiological and Progression Factors. London: CRC Press, 1994: 49-55.
19. Wejstal R, Widell A, Norkrans G. Hepatitis C virus infection with progression to hepatocellular carcinoma: A report of five prospectively followed patients in Sweden. Scand J Infect Dis 1993; 25: 417-20.
20. Horiike N, Nonaka T, Kajino K, Onji M, Ohata Y. Hepatitis C virus plus- and minus strand RNA in hepatocellular carcinoma and adjoining nontumorous liver. J Med Virol 1993; 41: 312-5.
21. Kiyosawa K, Soderyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5.